145 related articles for article (PubMed ID: 30897229)
1. Overexpression of cyclin-dependent kinase 4 protein in extramammary Paget's disease.
Urata K; Kajihara I; Myangat TM; Tasaki Y; Otsuka-Maeda S; Sawamura S; Kanazawa-Yamada S; Sakamoto R; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Ihn H
J Dermatol; 2019 May; 46(5):444-448. PubMed ID: 30897229
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
5. CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Oda Y; Ito T
Front Oncol; 2021; 11():710378. PubMed ID: 34395284
[TBL] [Abstract][Full Text] [Related]
6. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
[TBL] [Abstract][Full Text] [Related]
7. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
8. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
10. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
11. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
13. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
14. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
15. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
17. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease.
Chen SY; Moroi Y; Urabe K; Takeuchi S; Kido M; Hayashida S; Uchi H; Uenotsuchi T; Tu YT; Furue M
Arch Dermatol Res; 2008 Apr; 300(4):195-201. PubMed ID: 18210145
[TBL] [Abstract][Full Text] [Related]
18. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
19. Depigmented genital extramammary Paget's disease: a possible histogenetic link to Toker's clear cells and clear cell papulosis.
Chen YH; Wong TW; Lee JY
J Cutan Pathol; 2001 Feb; 28(2):105-8. PubMed ID: 11168760
[TBL] [Abstract][Full Text] [Related]
20. PI3K, Rac1 and pPAK1 are overexpressed in extramammary Paget's disease.
Qian Y; Zhang N; Chen S; Chu S; Feng A; Liu H
J Cutan Pathol; 2012 Nov; 39(11):1010-5. PubMed ID: 22845716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
